[{"Assets_0_Q3_USD":5977475000.0,"CIK":"1048477","CommonStockSharesConverted_0_Q3_shares":183567424.0,"CommonStockSharesOutstanding_0_Q3_shares":183567424.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-0.2,"EarningsPerShareBasic_3_Q3_USD":-0.03,"EarningsPerShareDiluted_1_Q3_USD":-0.2,"EarningsPerShareDiluted_3_Q3_USD":-0.03,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":293356000.0,"NetIncomeLossConverted_1_Q3_USD":-36494000.0,"NetIncomeLossConverted_3_Q3_USD":-6182000.0,"OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q3_USD":408742000.0,"RevenuesConverted_3_Q3_USD":1396465000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":4266149000.0,"Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":183214000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":182616000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":183214000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":182616000.0,"filed":"20211029","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2021.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20210930","qtrs":"0","uom":"USD"}]